Tender

Primary Blood Grouping MSC

NHS BLOOD AND TRANSPLANT

This public procurement record has 1 release in its history.

Tender

13 Apr 2022 at 20:26

Tender Notice
Summary of the contracting process

The NHS Blood and Transplant is seeking suppliers for the "Primary Blood Grouping MSC" service, which is integral to the health care industry. This selective tender, with competitive negotiation, aims to establish an end-to-end integrated service encompassing equipment, goods, installation, maintenance, and ongoing support for blood donation screening. The tender period concludes on 28 April 2022, while the contract is set to commence on 1 April 2023 and last until 31 March 2033. Delivery will primarily occur at two NHSBT sites located in Manchester and Filton, with a total contract value estimated at £50 million.

This procurement presents significant opportunities for businesses, particularly those involved in healthcare technology, diagnostic equipment, and related services. Companies that manufacture or supply CE/UKCA marked in vitro diagnostic devices, automation systems, and blood analysis services would be particularly well-suited to compete. Successful candidates will not only need to accommodate current technological standards but also anticipate and integrate future digital innovations for an effective partnership with NHSBT.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Primary Blood Grouping MSC

Notice Description

NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated Service, which must include all the necessary Equipment, Goods, Installation, maintenance, Consumables, Reagents, Software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, Instruments, Consumables and Reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end Service must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) (or any replacement system) without the need for changes to PULSE (or any replacement system). The Equipment should also be compatible with NHSBT's manufactured reagents and where possible, with those from third party reagent suppliers. NHSBT requires a high throughput blood and non-blood donation screening for primary blood grouping testing system(s), for ABO and Rh D typing (as a minimum DIV, DV and DVI), antibody screening and red cell phenotyping including Rh for donor blood samples. As a minimum, the Service provided must be capable of undertaking the testing of blood and non-blood donor samples and providing accurate results for the following:* ABO group* Rh phenotype D, C, c, E, e * Kell * Atypical antibody screen* High titre anti-A and anti-B screening* Red cell phenotypes S, s, Jka, Jkb (test system should include an option of Cw and M). All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors. The annual estimated throughput of the NHSBT primary automated blood sample testing equipment tests approximately 1,500,000 to 1,700,000 donations (of which ca. 1500 - 2100 are non-blood donors) are tested per annum across two NHSBT testing sites, namely Manchester and Filton. The Tenderer must also be able to accommodate technological and digital changes in the current and future such that NHSBT is able to access the state-of-the art digital developments and IT solutions in the diagnostics market.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/b5f5871a-5d73-4529-b06e-40295db39c49
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Competitive procedure with negotiation (above threshold)
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

38 - Laboratory, optical and precision equipments (excl. glasses)

48 - Software package and information systems

71 - Architectural, construction, engineering and inspection services

73 - Research and development services and related consultancy services

85 - Health and social work services

CPV Codes

33696200 - Blood-testing reagents

38434520 - Blood analysers

48921000 - Automation system

71632000 - Technical testing services

73430000 - Test and evaluation

85111810 - Blood analysis services

Notice Value(s)

Tender Value
£50,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
13 Apr 20223 years ago
Submission Deadline
28 Apr 2022Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
31 Mar 2023 - 31 Mar 2033 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Paul Jones
Contact Email
paul.jones@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
FILTON, BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified
Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577-2022-04-13T21:26:55+01:00",
    "date": "2022-04-13T21:26:55+01:00",
    "ocid": "ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-0773600D0O000000rwimUAA1",
        "title": "Primary Blood Grouping MSC",
        "description": "NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated Service, which must include all the necessary Equipment, Goods, Installation, maintenance, Consumables, Reagents, Software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, Instruments, Consumables and Reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end Service must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) (or any replacement system) without the need for changes to PULSE (or any replacement system). The Equipment should also be compatible with NHSBT's manufactured reagents and where possible, with those from third party reagent suppliers. NHSBT requires a high throughput blood and non-blood donation screening for primary blood grouping testing system(s), for ABO and Rh D typing (as a minimum DIV, DV and DVI), antibody screening and red cell phenotyping including Rh for donor blood samples. As a minimum, the Service provided must be capable of undertaking the testing of blood and non-blood donor samples and providing accurate results for the following:* ABO group* Rh phenotype D, C, c, E, e * Kell * Atypical antibody screen* High titre anti-A and anti-B screening* Red cell phenotypes S, s, Jka, Jkb (test system should include an option of Cw and M). All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors. The annual estimated throughput of the NHSBT primary automated blood sample testing equipment tests approximately 1,500,000 to 1,700,000 donations (of which ca. 1500 - 2100 are non-blood donors) are tested per annum across two NHSBT testing sites, namely Manchester and Filton. The Tenderer must also be able to accommodate technological and digital changes in the current and future such that NHSBT is able to access the state-of-the art digital developments and IT solutions in the diagnostics market.",
        "datePublished": "2022-04-13T21:26:55+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "73430000",
            "description": "Test and evaluation"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "48921000",
                "description": "Automation system"
            },
            {
                "scheme": "CPV",
                "id": "38434520",
                "description": "Blood analysers"
            },
            {
                "scheme": "CPV",
                "id": "71632000",
                "description": "Technical testing services"
            },
            {
                "scheme": "CPV",
                "id": "33696200",
                "description": "Blood-testing reagents"
            },
            {
                "scheme": "CPV",
                "id": "85111810",
                "description": "Blood analysis services"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "BS34 7QH"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 50000000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Competitive procedure with negotiation (above threshold)",
        "tenderPeriod": {
            "endDate": "2022-04-28T12:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2023-04-01T00:00:00+01:00",
            "endDate": "2033-03-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/b5f5871a-5d73-4529-b06e-40295db39c49",
                "datePublished": "2022-04-13T21:26:55+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-204412",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant"
            },
            "address": {
                "streetAddress": "500, North Bristol Park",
                "locality": "Filton, Bristol",
                "postalCode": "BS34 7QH",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Paul Jones",
                "email": "paul.jones@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-204412",
        "name": "NHS Blood and Transplant"
    }
}